Research output per year
Research output per year
Fingerprint
Dive into the research topics where Martine Lips is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Cost-effectiveness of the fixed-dose combination tiotropium/olodaterol versus tiotropium monotherapy or a fixed-dose combination of long-acting β2-agonist/inhaled corticosteroid for COPD in Finland, Sweden and the Netherlands: A model-based study
Hoogendoorn, M., Corro Ramos, I., Soulard, S., Cook, J., Soini, E., Paulsson, E. & Rutten-Van Mölken, M., 4 Aug 2021, In: BMJ Open. 11, 8, e049675.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile3 Citations (Scopus)15 Downloads (Pure) -
Performance of the EQ-5D-5L Plus Respiratory Bolt-On in the Birmingham Chronic Obstructive Pulmonary Disease Cohort Study
Hoogendoorn - Lips, EJI., Jowett, S., Dickens, A. P., Jordan, R., Enocson, A., Adab, P., Versteegh, MM. & Rutten - van Molken, MPMH., 1 Nov 2021, In: Value in Health. 24, 11, p. 1667-1675 9 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile9 Downloads (Pure) -
Talking the same language on patient empowerment: Development and content validation of a taxonomy of self-management interventions for chronic conditions
COMPAR-EU Group, 12 Jul 2021, In: Health Expectations.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile5 Citations (Scopus)20 Downloads (Pure) -
How to Address Uncertainty in Health Economic Discrete-Event Simulation Models: An Illustration for Chronic Obstructive Pulmonary Disease
Corro Ramos, I., Hoogendoorn - Lips, M. & Rutten - van Molken, M., 2020, In: Medical Decision Making. 40, p. 619-632 14 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile9 Citations (Scopus)9 Downloads (Pure) -
Rituximab-CHOP With Early Rituximab Intensification for Diffuse Large B-Cell Lymphoma: A Randomized Phase III Trial of the HOVON and the Nordic Lymphoma Group (HOVON-84)
Lugtenburg, E., Brown, PD., van der Holt, R., D'Amore, FA., Koene, HR., de Jongh, E., Fijnheer, R., van Esser, JW., Bohmer, LH., Pruijt, JFM., Verhoef, GE., Hoogendoorn - Lips, M., Bilgin, MY., Nijland, M., van der Burg-de Graauw, NC., Oosterveld, M., Jie, KS., Larsen, TS., van der Poel, MWM., Leijs, MB., & 14 others, 2020, In: Journal of Clinical Oncology. 38, 29Research output: Contribution to journal › Article › Academic › peer-review
28 Citations (Scopus)